Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats

This publication has 36 references indexed in Scilit:

• Early Expression and Cellular Localization of Proinflammatory Cytokines Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Human Traumatic Spinal Cord Injury
  Spine, 2004
• Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings
  Neurosurgical Review, 2004
• Blockade of interleukin‐6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury
  Journal of Neuroscience Research, 2004
• Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion
  Journal of Neuroscience Research, 2002
• Erythropoietin Receptor-mediated Inhibition of Exocytotic Glutamate Release Confers Neuroprotection during Chemical Ischemia
  Published by Elsevier ,2001
• Rapid Upregulation of Caspase-3 in Rat Spinal Cord after Injury: mRNA, Protein, and Cellular Localization Correlates with Apoptotic Cell Death
  Experimental Neurology, 2000
• A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice
  Journal of Cerebral Blood Flow & Metabolism, 1999
• The Influence of Recombinant Human Erythropoietin on Tumor Necrosis Factor α and Interleukin‐10 Production by Whole Blood Cell Cultures in Hemodialysis Patients
  Artificial Organs, 1998
• Update on the Pathophysiology and Pathology of Acute Spinal Cord Injury
  Brain Pathology, 1995
• The molecular mechanism of erythropoietin action
  European Journal of Biochemistry, 1992